ISRCTN17674794已完成未知
PRAME immunohistochemistry for melanoma: a STARD-compliant diagnostic accuracy study
niversity of Kansas Medical Center0 个研究点目标入组 143 人开始时间: 2021年11月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 143
研究概览
简要总结
2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35672262/ (added 20/09/2022)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Pathology sample of a primary pigmented skin lesion
- •2. PRAME immunohistochemistry performed on that sample prior to final diagnosis
- •3. MART1 immunohistochemistry performed on that sample prior to final diagnosis
排除标准
- •1. Uncertain final diagnosis (e.g., MELTUMP)
- •2. Re-excision
- •3. Spindle cell melanoma
- •4. Desmoplastic melanoma
- •5. Metastatic melanoma
- •6. Nonmelanocytic lesion
- •7. Missing slides
- •8. Unreadable PRAME or MART1 slides due to technical error
研究者
相似试验
Unknown
不适用
PRAME Immunohistochemistry as an Adjunct for Evaluating Ambiguous Melanocytic ProliferationMelanomaNCT05089188University Hospital, Strasbourg, France55
已完成
1 期
Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma PatientsMalignant MelanomaNCT00306566Cytos Biotechnology AG
Unknown
不适用
The Identification of Novel Prognostic Markers in MelanomaMalignant MelanomaNCT01002560Royal Marsden NHS Foundation Trust500
终止
2 期
Immunologic Determinants of Response to Pembrolizumab (MK-3475) in Advanced Melanoma (MK-3475-161/KEYNOTE-161)Advanced MelanomaNCT03407170Merck Sharp & Dohme LLC1
已完成
不适用
Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With MelanomaMelanoma (Skin)NCT00004153University of Chicago106